Richard C. Mohs - Concepedia

Author

Richard C. Mohs

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Humberto Arboleda, Joel Raskin, Mohs R, R C Mohs, R MOHS, R Mohs, R. C. MOHS, R. C. Mohs, R. Mohs, R.C Mohs

386

Publications

58.9K

Citations

H-Index

147

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Eli Lilly (United States)United States Department of Veterans Affairs Mount Sinai Hospital University of California San Diego

About

Richard C. Mohs is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, psychiatry, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	50	118	16.9K
2	Health Sciences	22	28	3.7K
3	Public Health	4	4	115
4	Education	1	1	43
5	Nursing	1	1	44

Richard C. Mohs

194

Publications

52.1K

Citations

H-Index

Page 1

	Year	Citations
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Guy M. McKhann, David S. Knopman, Howard Chertkow, Alzheimer s & Dementia	2011	18.4K
A new rating scale for Alzheimer's disease Wilma G. Rosen, Richard C. Mohs, Kenneth L. Davis American Journal of Psychiatry NeuropsychologyAlzheimer's DiseasePsychiatryGeriatricsFinal Scale	1984	4.1K
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease J. C. Moms, Albert Heyman, Richard C. Mohs, Neurology	1989	4.1K
Practice parameter: Management of dementia (an evidence-based review) [RETIRED] Rachelle S. Doody, J E Stevens, C. Beck, Neurology	2001	1.7K
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, New England Journal of Medicine	2014	1.6K
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease Samantha Rogers, Martin R. Farlow, Rachelle S. Doody, Neurology NeuropsychologyPlacebo-controlled TrialPharmacotherapyCognitive RehabilitationGeriatric Neurology	1998	1.6K
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease Rachelle S. Doody, Rema Raman, Martin R. Farlow, New England Journal of Medicine	2013	1.2K
Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. John C. Morris, Richard C. Mohs, Heather Rogers, PubMed Neurodegenerative DiseasesNeuropsychologyAlzheimer's DiseaseNeuropsychological AssessmentVascular Dementia	1988	1.1K
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery K. A. Welsh, Nelson Butters, Richard C. Mohs, Neurology	1994	950
Detection of Abnormal Memory Decline in Mild Cases of Alzheimer's Disease Using CERAD Neuropsychological Measures Katherine M. Welsh, Nelson Butters, James P. Hughes, Archives of Neurology NeuropsychologyMild CasesCerad PatientsCognitive RehabilitationSocial Sciences	1991	732

Page 1